3个交易日涨超18%,康希诺称mRNA疫苗研发等尚处早期,公司上半年营收大增、亏损收窄

深圳商报·读创
Oct 02

3个交易日股价累计涨幅超18%,康希诺(688185)9月30日晚间发布股票交易异常波动公告称,公司正在推进mRNA疫苗研发工作以及In Vivo CAR相关疗法的开发,目前均处于早期阶段。  公告称,公司股票于2026年9月28日、9月29日及9月30日连续3个交易日内日收盘价格涨幅偏离值累计超过30%,属于股票交易异常波动情形。经公司自查,公司目前生产经营活动正常,内部经营秩序正常。公司所处...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10